Meliha C Kapetanovic

Medicin och livsvetenskap

1. Rheumatoid Arthritis 100%
2. Pneumococcal Vaccines 69%
3. Conjugate Vaccines 68%
4. Vaccination 59%
5. Arthritis 41%
6. Antibody Formation 38%
7. Methotrexate 35%
8. Tumor Necrosis Factor Inhibitors 35%
9. Antirheumatic Agents 35%
10. Sweden 32%
11. Gout 29%
12. Spondylarthropathies 20%
13. Rheumatic Diseases 20%
14. Infliximab 19%
15. Etanercept 19%
16. Serogroup 17%
17. Antibodies 17%
18. Pneumococcal Infections 17%
19. Abatacept 16%
20. Rituximab 16%
21. 13-valent pneumococcal vaccine 15%
22. Therapeutics 14%
23. Ankylosing Spondylitis 13%
24. Cohort Studies 12%
25. Immunization 12%
26. Comorbidity 11%
27. Vaccines 11%
28. Observational Studies 11%
29. Heptavalent Pneumococcal Conjugate Vaccine 10%
30. tocilizumab 10%
31. Pharmaceutical Preparations 9%
32. Prednisolone 9%
33. Joint Diseases 9%
34. Joints 9%
35. Immunoglobulins 9%
36. 23-valent pneumococcal capsular polysaccharide vaccine 8%
37. Cartilage Oligomeric Matrix Protein 8%
38. Tumor Necrosis Factor-alpha 8%
39. Incidence 8%
40. Immunoglobulin G 7%
41. Treatment Adherence and Compliance 7%
42. belimumab 7%
43. Smoking 7%
44. Crystal Arthropathies 7%
45. Confidence Intervals 7%
46. Infections 7%
47. Adalimumab 6%
48. B-Lymphocytes 6%
49. Cardiovascular Diseases 6%
50. Leflunomide 6%